Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Shell Asset Management Co.

Shell Asset Management Co. trimmed its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 14.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 22,775 shares of the medical research company’s stock after selling 3,845 shares during the period. Shell Asset Management Co.’s holdings in Thermo Fisher Scientific were worth $6,459,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of TMO. Orser Capital Management LLC grew its holdings in Thermo Fisher Scientific by 3.6% in the fourth quarter. Orser Capital Management LLC now owns 11,586 shares of the medical research company’s stock valued at $3,766,000 after purchasing an additional 406 shares during the period. Capital Investment Advisors LLC acquired a new stake in Thermo Fisher Scientific in the fourth quarter valued at approximately $217,000. NEXT Financial Group Inc grew its holdings in Thermo Fisher Scientific by 1.8% in the fourth quarter. NEXT Financial Group Inc now owns 2,040 shares of the medical research company’s stock valued at $663,000 after purchasing an additional 36 shares during the period. RFG Advisory LLC grew its holdings in Thermo Fisher Scientific by 83.0% in the fourth quarter. RFG Advisory LLC now owns 1,495 shares of the medical research company’s stock valued at $486,000 after purchasing an additional 678 shares during the period. Finally, SeaCrest Wealth Management LLC grew its holdings in Thermo Fisher Scientific by 13.0% in the fourth quarter. SeaCrest Wealth Management LLC now owns 1,624 shares of the medical research company’s stock valued at $528,000 after purchasing an additional 187 shares during the period. 88.68% of the stock is currently owned by institutional investors.

In other Thermo Fisher Scientific news, COO Mark Stevenson sold 25,000 shares of Thermo Fisher Scientific stock in a transaction on Friday, April 24th. The stock was sold at an average price of $328.03, for a total value of $8,200,750.00. Following the sale, the chief operating officer now owns 73,538 shares in the company, valued at $24,122,670.14. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Marc N. Casper sold 30,000 shares of Thermo Fisher Scientific stock in a transaction on Tuesday, April 28th. The shares were sold at an average price of $333.02, for a total value of $9,990,600.00. Following the completion of the sale, the chief executive officer now owns 304,946 shares in the company, valued at approximately $101,553,116.92. The disclosure for this sale can be found here. 0.45% of the stock is owned by insiders.

Thermo Fisher Scientific stock traded up $4.51 during trading on Friday, reaching $340.26. 1,097,619 shares of the company were exchanged, compared to its average volume of 1,572,086. Thermo Fisher Scientific Inc. has a 52-week low of $250.21 and a 52-week high of $351.86. The company has a market capitalization of $132.60 billion, a P/E ratio of 37.31, a PEG ratio of 2.25 and a beta of 1.04. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.32 and a quick ratio of 1.69. The stock’s 50 day simple moving average is $324.75 and its two-hundred day simple moving average is $317.43.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings data on Wednesday, April 22nd. The medical research company reported $2.94 EPS for the quarter, topping the Zacks’ consensus estimate of $2.79 by $0.15. Thermo Fisher Scientific had a return on equity of 17.25% and a net margin of 14.31%. The firm had revenue of $6.23 billion for the quarter, compared to the consensus estimate of $6.18 billion. During the same quarter last year, the business posted $2.81 earnings per share. The firm’s revenue was up 1.7% compared to the same quarter last year. As a group, equities analysts forecast that Thermo Fisher Scientific Inc. will post 11.92 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Monday, June 15th will be given a $0.22 dividend. The ex-dividend date of this dividend is Friday, June 12th. This represents a $0.88 dividend on an annualized basis and a yield of 0.26%. Thermo Fisher Scientific’s dividend payout ratio is currently 7.13%.

Several analysts have commented on the company. Wells Fargo & Co raised their price objective on Thermo Fisher Scientific from $300.00 to $340.00 and gave the company an “equal weight” rating in a report on Tuesday, April 21st. Needham & Company LLC raised their price objective on Thermo Fisher Scientific from $341.00 to $383.00 in a report on Thursday, April 23rd. SVB Leerink raised their target price on Thermo Fisher Scientific from $330.00 to $365.00 and gave the company an “outperform” rating in a research report on Thursday, April 23rd. Robert W. Baird raised their target price on Thermo Fisher Scientific from $340.00 to $341.00 and gave the company an “outperform” rating in a research report on Wednesday, March 4th. Finally, Stifel Nicolaus decreased their target price on Thermo Fisher Scientific from $345.00 to $315.00 and set a “buy” rating on the stock in a research report on Thursday, April 2nd. Four analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Thermo Fisher Scientific presently has an average rating of “Buy” and a consensus target price of $347.21.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

See Also: Municipal Bonds

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.